Keyphrases
Helicobacter Pylori (H. pylori)
100%
Urea Breath Test
45%
Inflammatory Bowel Disease
43%
Crohn's Disease
39%
Thioacetamide
34%
Helicobacter Pylori Infection
30%
Proton Pump Inhibitors
29%
Liver Damage
28%
Concanavalin A (Con A)
25%
P27Kip1
25%
Achalasia
23%
Tumor Necrosis Factor-α
21%
Colonoscopy
21%
High-resolution Manometry
21%
Israeli
19%
Breath Test
19%
Hepatic Damage
18%
Liver Cirrhosis
18%
Israel
18%
Apoptosis
18%
Iron Deficiency Anemia
18%
Glucagon-like peptide-1 Receptor (GLP-1R)
17%
High-resolution Esophageal Manometry
17%
Concanavalin A-induced Hepatitis
16%
Glucagon-like
16%
Colon Cancer Cells
13%
A1 Receptor
13%
Liver Enzymes
12%
Liver Injury
12%
Hypothyroidism
12%
Receptor Expression
12%
Helicobacter Pylori Eradication
12%
Esophagogastroduodenoscopy
12%
Clinical Presentation
11%
Liver
11%
Gastric Cancer
11%
Serum Levels
11%
Endoscopy
10%
Fulminant Hepatic Failure
10%
Celiac Disease
10%
Etiology
10%
Dimethyl Sulfoxide
10%
Arg-Gly-Asp
10%
Gastroenterologist
10%
Dysphagia
10%
Gastric Epithelial Cells
10%
Diabetic Patients
9%
Immune Response
9%
Dimethylthiourea
9%
Integrated Relaxation Pressure
9%
Pharmacology, Toxicology and Pharmaceutical Science
Helicobacter Pylori
66%
Liver Injury
55%
Urea Breath Test
35%
Thioacetamide
33%
Urea C 13
33%
Tumor Necrosis Factor
25%
Crohn's Disease
24%
Proton Pump Inhibitor
24%
Concanavalin A
21%
Liver Cirrhosis
19%
Diseases
19%
Inflammatory Bowel Disease
17%
Concanavalin A-Induced Hepatitis
16%
Liver Enzyme
14%
Colon Carcinoma
14%
Hypothyroidism
12%
Colorectal Carcinoma
12%
Abdominal Cancer
12%
Infection
11%
Prevalence
10%
Fulminant Hepatic Failure
10%
Dimethyl Sulfoxide
10%
Arginylglycylaspartic Acid
10%
Inflammation
10%
Helicobacter Infection
10%
Receptor
10%
Dimethylthiourea
9%
Placebo
9%
Diabetes Mellitus
9%
Fatty Liver
9%
Neoplasm
9%
Carbon 13
8%
Adhesive Agent
8%
Experimental Liver Injury
8%
Liver Disease
8%
Hydroxyl Radical
8%
Octanoic Acid
8%
Glucagon Like Peptide 1 Receptor Agonist
8%
Ulcerative Colitis
8%
Aminotransferase
7%
Malignant Neoplasm
7%
Clinical Trial
7%
Carcinogenesis
7%
Integrin Receptor
6%
Triacylglycerol
6%
Cyclin Dependent Kinase Inhibitor
6%
Phosphotransferase
6%
Omeprazole
6%
Cytokine
6%
Inosine Phosphate
6%
Medicine and Dentistry
Helicobacter Pylori
79%
Urea Breath Test
27%
High Resolution Manometry
26%
Achalasia
25%
Prevalence
24%
Urea C 13
24%
Breathing
22%
Colonoscopy
21%
Endoscopy
21%
Diseases
19%
Inflammatory Bowel Disease
19%
Crohn's Disease
18%
Hypochromic Anemia
17%
Proton-Pump Inhibitor
16%
Infection
15%
Plummer-Vinson Syndrome
15%
Gastritis
13%
Receptor Expression
12%
Esophagogastroduodenoscopy
12%
Diabetes Mellitus
11%
Esophagus
11%
Coeliac Disease
11%
Helicobacter Infection
10%
Manometry
10%
Stomach Mucosa
10%
Muscle Contractility
9%
Glucagon Like Peptide 1 Receptor
9%
Iron
9%
Colorectal Carcinoma
8%
Diabetes
8%
Adenoma
8%
Biological Therapy
8%
Hepatitis C
8%
Lymphatic Follicle
8%
Primary Health Care
8%
Satiety
8%
Glucagon-Like Peptide-1 Agonist
8%
Membrane Transport Protein
8%
Ethnic Difference
8%
Prospective Study
7%
Ulcerative Colitis
7%
Carbon 13
7%
Health Care Cost
7%
Cancer
7%
Ulcer
7%
Gastroesophageal Reflux
6%
Nonsteroid Antiinflammatory Agent
6%
Motility Disorder
6%
Gastroenterology
6%
Cyclin Dependent Kinase Inhibitor
6%
